162 related articles for article (PubMed ID: 32269833)
1. The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells.
Alshangiti AM; Togher KL; Hegarty SV; Sullivan AM; O'Keeffe GW
Neuronal Signal; 2019 Mar; 3(1):NS20180201. PubMed ID: 32269833
[TBL] [Abstract][Full Text] [Related]
2. 4-Hydroxychalcone Induces Cell Death via Oxidative Stress in
Alshangiti AM; Tuboly E; Hegarty SV; McCarthy CM; Sullivan AM; O'Keeffe GW
Oxid Med Cell Longev; 2019; 2019():1670759. PubMed ID: 31885773
[TBL] [Abstract][Full Text] [Related]
3. Novel Action of the Chalcone Isoliquiritigenin as a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor: Potential Therapy for Cholera and Polycystic Kidney Disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 32092841
[TBL] [Abstract][Full Text] [Related]
4. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
[TBL] [Abstract][Full Text] [Related]
5. JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.
Kuo YT; Liu YL; Adebayo BO; Shih PH; Lee WH; Wang LS; Liao YF; Hsu WM; Yeh CT; Lin CM
PLoS One; 2015; 10(5):e0125343. PubMed ID: 25951238
[TBL] [Abstract][Full Text] [Related]
6. Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.
Prochazka P; Hrabeta J; Vicha A; Cipro S; Stejskalova E; Musil Z; Vodicka P; Eckschlager T
Oncol Rep; 2013 Jun; 29(6):2415-21. PubMed ID: 23563570
[TBL] [Abstract][Full Text] [Related]
7. [A comprehensive analysis of potential prognostic biomarkers for MYCN-amplified neuroblastoma].
Fan X; Lu HT; Hou L; Zhang L; Yang BY; Chen WM; Zhang HY; Chen X; Li FJ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):262-268. PubMed ID: 32204764
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth.
Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW
Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630
[TBL] [Abstract][Full Text] [Related]
9. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
Prochazka P; Hrabeta J; Vícha A; Eckschlager T
Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line.
Wong KE; Mora MC; Sultana N; Moriarty KP; Arenas RB; Yadava N; Schneider SS; Tirabassi MV
Tumour Biol; 2018 Jun; 40(6):1010428318779515. PubMed ID: 29871587
[TBL] [Abstract][Full Text] [Related]
11. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
12. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.
Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A
J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881
[TBL] [Abstract][Full Text] [Related]
13. Link between spermine oxidase and apoptosis antagonizing transcription factor: A new pathway in neuroblastoma.
Fratini E; Cervelli M; Mariottini P; Kanamori Y; Amendola R; Agostinelli E
Int J Oncol; 2019 Nov; 55(5):1149-1156. PubMed ID: 31545418
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
[TBL] [Abstract][Full Text] [Related]
15. Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Paffhausen T; Schwab M; Westermann F
Cancer Lett; 2007 May; 250(1):17-24. PubMed ID: 17141950
[TBL] [Abstract][Full Text] [Related]
16. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Bogen D; Wei JS; Azorsa DO; Ormanoglu P; Buehler E; Guha R; Keller JM; Mathews Griner LA; Ferrer M; Song YK; Liao H; Mendoza A; Gryder BE; Sindri S; He J; Wen X; Zhang S; Shern JF; Yohe ME; Taschner-Mandl S; Shohet JM; Thomas CJ; Martin SE; Ambros PF; Khan J
Oncotarget; 2015 Nov; 6(34):35247-62. PubMed ID: 26497213
[TBL] [Abstract][Full Text] [Related]
17. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
18. Combination of Rapamycin and MK-2206 Induced Cell Death
Dong Y; Gong W; Hua Z; Chen B; Zhao G; Liu Z; Thiele CJ; Li Z
Front Pharmacol; 2020; 11():31. PubMed ID: 32116708
[TBL] [Abstract][Full Text] [Related]
19. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
20. Results of neuroblastoma treatment in Lithuania: a single centre experience.
Juškaitė A; Tamulienė I; Rascon J
Acta Med Litu; 2017; 24(2):128-137. PubMed ID: 28845131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]